Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention.
about
U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3.Antisense oligonucleotides as therapeutic agents.Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progressionNew advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system.Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.Clinical trials of a new class of therapeutic agents: antisense oligonucleotides.Walnut polyphenol metabolites, urolithins A and B, inhibit the expression of the prostate-specific antigen and the androgen receptor in prostate cancer cells.Chemopreventive effects of Rubus coreanus Miquel on prostate cancer.Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer.DE-71-induced apoptosis involving intracellular calcium and the Bax-mitochondria-caspase protease pathway in human neuroblastoma cells in vitro.Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cellsDifferential expression of cell death regulators in response to thapsigargin and adriamycin in Bcl-2 transfected DU145 prostatic cancer cells.Resistance to apoptosis should not be taken as a hallmark of cancer.Enhanced apoptosis under low serum conditions in human glioblastoma cells by connexin 43 (Cx43).Role of Mitochondria-Associated ER Membranes in Calcium Regulation in Cancer-Specific Settings.MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
P2860
Q24811943-78A6566F-1E9D-44BF-8C8E-FA6A34503372Q33738466-4F80A830-50E5-4F39-B2F1-D36007C4B6A1Q34374537-32308501-D896-45E6-804D-746C0A7B144CQ35149046-09CAE3C4-1EA3-46F9-8A59-9952CCB3DB84Q35809680-259531F0-741A-4C2A-804C-533F0DE8067AQ36179648-FCBB59C9-40BF-4801-A2B4-4302FB301C6EQ38957297-0CEEAA67-2DA1-4B42-967C-E0409A1B175CQ39367734-73586BB2-2EEF-4044-BB04-026762EF3050Q39568944-10F13806-E9B0-4F78-950D-9664EE2843DDQ39985831-DE856260-B139-42EE-A396-78459AA93BB8Q40631293-9934FB02-7407-4256-BF18-393882F478B9Q40817773-CB3C1A7C-513B-4553-B06E-C645FFA3D9A6Q41978677-6ABB8059-6D38-4BF2-BC24-932BCA978C97Q43825789-D8271F36-FCF6-496E-974F-A6F0C2B5540DQ53827160-0EA71D06-4196-4585-AE22-C3FB34D39AF1Q55281092-091B83D5-C18F-449A-A519-779F18D31A6E
P2860
Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Role of the Bcl-2 gene family ...... for therapeutic intervention.
@ast
Role of the Bcl-2 gene family ...... for therapeutic intervention.
@en
type
label
Role of the Bcl-2 gene family ...... for therapeutic intervention.
@ast
Role of the Bcl-2 gene family ...... for therapeutic intervention.
@en
prefLabel
Role of the Bcl-2 gene family ...... for therapeutic intervention.
@ast
Role of the Bcl-2 gene family ...... for therapeutic intervention.
@en
P2093
P2860
P921
P356
P1476
Role of the Bcl-2 gene family ...... for therapeutic intervention.
@en
P2093
P2860
P356
10.1289/EHP.99107S149
P478
107 Suppl 1
P577
1999-02-01T00:00:00Z